Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIAT
Ratios

Alx Oncology Holdings (ALXO) Accumulated Depreciation & Amortization (2019 - 2023)

Alx Oncology Holdings' Accumulated Depreciation & Amortization history spans 5 years, with the latest figure at $200000.0 for Q3 2023.

  • For Q3 2023, Accumulated Depreciation & Amortization changed 0.0% year-over-year to $200000.0; the TTM value through Sep 2023 reached $200000.0, changed 0.0%, while the annual FY2022 figure was $300000.0, 376.19% up from the prior year.
  • Accumulated Depreciation & Amortization for Q3 2023 was $200000.0 at Alx Oncology Holdings, down from $400000.0 in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $400000.0 in Q4 2019 and bottomed at $63000.0 in Q4 2021.
  • The 5-year median for Accumulated Depreciation & Amortization is $200000.0 (2020), against an average of $204200.0.
  • The largest annual shift saw Accumulated Depreciation & Amortization crashed 68.5% in 2021 before it skyrocketed 376.19% in 2022.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $400000.0 in 2019, then crashed by 50.0% to $200000.0 in 2020, then plummeted by 68.5% to $63000.0 in 2021, then surged by 376.19% to $300000.0 in 2022, then tumbled by 33.33% to $200000.0 in 2023.
  • Per Business Quant, the three most recent readings for ALXO's Accumulated Depreciation & Amortization are $200000.0 (Q3 2023), $400000.0 (Q2 2023), and $200000.0 (Q1 2023).